The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Open Access
- 1 October 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (43), 25752-25761
- https://doi.org/10.1074/jbc.270.43.25752
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.Proceedings of the National Academy of Sciences, 1994
- Lipid advanced glycosylation: pathway for lipid oxidation in vivo.Proceedings of the National Academy of Sciences, 1993
- Glucose and diabetic vascular disease 1The FASEB Journal, 1992
- Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.The Journal of Experimental Medicine, 1991
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Structure Elucidation of a Senescence Cross-Link from Human Extracellular MatrixJournal of Biological Chemistry, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Catalysis of lipid peroxidation by glucose and glycosylated collagenBiochemical and Biophysical Research Communications, 1988